Literature DB >> 10918666

Botulinum toxin for the treatment of spasmodic dysphonia.

S R Gibbs1, A Blitzer.   

Abstract

Spasmodic dysphonia is a focal laryngeal dystonia. Laryngeal dystonia presents as: adductor spasmodic dysphonia with the characteristic strain-strangle voice; abductor spasmodic dysphonia with hypophonia and breathy breaks in connected speech; and adductor respiratory dystonia with paradoxical vocal fold motion and intermittent stridor. Current treatment with periodic laryngeal intramuscular injections of botulinum toxin A has allowed patients to function more normally. In this article, the authors' treatment paradigm and experience in treating over 900 patients with laryngeal dystonia are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918666     DOI: 10.1016/s0030-6665(05)70249-8

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  3 in total

Review 1.  ["Off-label use" of botulinum toxin preparations in treatment of spasmodic dysphonia. Position of the German Society of Phoniatrics and Pediatric Audiology].

Authors:  M Ptok; R Schönweiler; T Nawka
Journal:  HNO       Date:  2004-01       Impact factor: 1.284

2.  Otolaryngology head and neck surgery: an integrative view of the larynx.

Authors:  Timothy M McCulloch; Douglas Van Daele; Michelle R Ciucci
Journal:  Head Neck       Date:  2011-09-09       Impact factor: 3.147

Review 3.  Focal dystonia: the role of botulinum toxin.

Authors:  R Tintner; J Jankovic
Journal:  Curr Neurol Neurosci Rep       Date:  2001-07       Impact factor: 5.081

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.